Zhang Yifan, Li Hongkun, Jiang Na, Ru Qingjing
The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
Front Pharmacol. 2025 Aug 25;16:1626251. doi: 10.3389/fphar.2025.1626251. eCollection 2025.
Hepatocellular carcinoma (HCC) is a prevalent malignant neoplasm of the digestive system, including 80% of primary liver malignancies. The Wnt/β-catenin signaling pathway plays a key role in immune response and tumer resistance. A growing number of studies have shown that the Wnt/β-catenin signaling pathway is involved in the pathogenesis of HCC. The Wnt/β-catenin pathway affects HCC in a variety of ways, including by influencing gene mutations, regulating dendritic cells, T-cells, and tumor cells, and influencing tumer resistance. Presently, conventional chemotherapy exhibits several drawbacks, including side effects, restrictions, and the emergence of tumer resistance. Traditional Chinese medicine (TCM) are characterized by multiple actions, multiple targets, few side effects, and improved immunity, and their combination with common clinical therapies can prolong patient survival and reduce postoperative recurrence rates, providing a new idea of combination therapy for the alleviation and improvement of HCC. This review focuses on TCM as an adjunct to surgery, targeted therapy, interventional therapy to improve the HCC microenvironment, reverse tumer resistance, and reduce treatment side effects by modulating the Wnt signaling pathway. It should be clear that TCM should not replace the first-line treatment plan of modern medicine, and its core value is to improve the comprehensive efficacy and quality of life of patients. This research examines the role of the Wnt/β-catenin signalling system in developing HCC and describes how TCM and plant active metabolites, crude extracts of single botanical drugs and Chinese herbal formulations affect the progression of HCC by modulating different targets of the Wnt/β-catenin signalling pathway or by modulating other pathways related to the Wnt/β-catenin signalling pathway. This review is intended to provide new ideas and options for the prevention and treatment of HCC.
肝细胞癌(HCC)是消化系统中一种常见的恶性肿瘤,占原发性肝脏恶性肿瘤的80%。Wnt/β-连环蛋白信号通路在免疫反应和肿瘤耐药中起关键作用。越来越多的研究表明,Wnt/β-连环蛋白信号通路参与了HCC的发病机制。Wnt/β-连环蛋白通路以多种方式影响HCC,包括影响基因突变、调节树突状细胞、T细胞和肿瘤细胞,以及影响肿瘤耐药性。目前,传统化疗存在一些缺点,包括副作用、限制和肿瘤耐药性的出现。中药具有多靶点、多作用、副作用少和提高免疫力的特点,与临床常用疗法联合使用可延长患者生存期并降低术后复发率,为缓解和改善HCC提供了联合治疗的新思路。本综述重点关注中药作为手术、靶向治疗、介入治疗的辅助手段,通过调节Wnt信号通路改善HCC微环境、逆转肿瘤耐药性并减少治疗副作用。需要明确的是,中药不应取代现代医学的一线治疗方案,其核心价值在于提高患者的综合疗效和生活质量。本研究探讨了Wnt/β-连环蛋白信号系统在HCC发生发展中的作用,并描述了中药及植物活性代谢产物、单味植物药粗提物和中药复方制剂如何通过调节Wnt/β-连环蛋白信号通路的不同靶点或通过调节与Wnt/β-连环蛋白信号通路相关的其他途径来影响HCC的进展。本综述旨在为HCC的预防和治疗提供新的思路和选择。